SNDX
Syndax Pharmaceuticals Inc.
Latest News for SNDX
In a report released today, from Mizuho Securities maintained a Buy rating on Syndax Pharmaceuticals, with a price target of $45.00. In a report re......
In a report released today, Jason Zemansky from Bank of America Securities reiterated a Buy rating on Syndax Pharmaceuticals, with a price target o......
In a report released today, Stephen Willey from Stifel Nicolaus maintained a Buy rating on Syndax Pharmaceuticals, with a price target of $44.00. T......
Barclays analyst Peter Lawson maintained a Buy rating on Syndax Pharmaceuticals today and set a price target of $19.00. The company’s shares closed......
The latest update is out from Syndax Pharmaceuticals ( ($SNDX) ). On October 24, 2025, Syndax Pharmaceuticals announced that the FDA approved Revuf......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SNDX | $17.44 | +2.3% | 1.87M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Syndax Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW